目次
Chapter- 1: Introduction
Study Background
Study Goals and Objectives
Reasons for Doing this Study
Scope of Report
What's New in this Update
COVID-19 Update
Information Sources
Methodology
Geographic Breakdown
Analyst's Credentials
BCC Custom Research
Related BCC Research Reports
Chapter- 2: Summary and Highlights
Table 0A : Global Market for Vaccine Technologies, by Vaccine Type, Through 2026
Figure 0A : Global Market for Vaccine Technologies, by Vaccine Type, 2019-2026
Table 0B : Global Market for COVID-19 Vaccines, Through 2026
Figure 0B : Global Market for COVID-19 Vaccines, 2019-2026
Chapter- 3: Market and Technology Background
Definitions
Immune System and Vaccines
History of Vaccines
Vaccines and Immunization, Overview
Immunization
Adjuvants and Excipients
Infectious Diseases Preventable by Vaccine
Human Diseases
Regulatory Aspects
Chapter- 4: Global Market for COVID-19 Vaccines
Overview
COVID-19 Vaccine Technologies
Advent of mRNA Technology
Impact of COVID-19 on Routine Infant Vaccination
COVID-19 Disruptions
Stagnating Global Coverage Rate
Progress and Challenges by Country and Region
Chapter- 5: Market Dynamics
Market Drivers
Market Restraints
Market Opportunities
Competitive Landscape
Chapter- 6: Market Breakdown by Technology
Global Market for Vaccine Technologies by Vaccine Type
Chapter- 7: Market Breakdown by Disease
Global Market for Vaccine Technologies by Disease
Chapter- 8: Market Breakdown by Age Group Treated
Global Market for Vaccine Technologies by Age Group Treated
Chapter- 9: Market Breakdown by Region
Global Market for Vaccine Technologies by Region
Chapter- 10: Company Profiles
ABBOTT LABORATORIES
ASTRAZENECA
BAVARIAN NORDIC A/S
BHARAT BIOTECH INTERNATIONAL LTD.
EMERGENT BIOSOLUTIONS INC.
GLAXOSMITHKLINE PLC
JOHNSON & JOHNSON INC.
MERCK & CO. INC
MITSUBISHI TANABE PHARMA CORP.
PANACEA BIOTEC LTD.
PFIZER INC.
SANOFI PASTEUR SA
Chapter- 11: Appendix: List of Acronyms
Table 83 : Acronyms Used in This Report
